close
MENU
Senior journalist
Senior journalist

Maria Slade

Maria Slade is the NZ Shareholders Association 2021 Business Journalist of the Year. She was also the New Zealand runner-up in the 2021 Citi Journalism Awards.

Her first job out of journalism school was with NBR, and she rejoined us in 2020 after a successful career as a reporter, editor, author and commentator. She has worked for most major New Zealand media outlets including the New Zealand Herald, Stuff, NewstalkZB and Radio New Zealand. Her most recent role was as business editor of the independent current affairs website, The Spinoff. She is the author of a how-to book for house hunters, Buyer Beware: A New Zealand Home Buyer’s Guide, and once got so passionate about the state of the New Zealand wool industry that she found funding to attend a Las Vegas carpet conference (the story won an award).

Maria’s career has taken her from print to radio, business to news, but it is business writing that has most captured her attention. One of her roles is editor of the annual The NBR List.

 

Maria Slade 's Articles
Law

What is an employee? Government about to change definition

Read Article
Thu, 13 Oct 2022

Will Wayne Brown stand up over Light Rail?

Read Article
Wed, 12 Oct 2022
Law

Jami-Lee Ross not guilty on political donations charges

Read Article
Wed, 05 Oct 2022

U-turn on marketing plan for Wellington Serepisos property

Read Article
Wed, 05 Oct 2022

Hawaiian court orders New Zealand director to pay $3.7m

Read Article
Mon, 03 Oct 2022

Rattle your dags, National, and tell us your climate policy

Read Article
Wed, 28 Sep 2022
Law

All the King’s men and women: Taking silk in a new era

Read Article
Fri, 23 Sep 2022
Law

Hong Kong Police investigating Paul Bublitz for fraud

Read Article
Wed, 21 Sep 2022

‘Friends in decarbonising places’: EU warning for New Zealand

Read Article
Wed, 21 Sep 2022

Banks make more healthy profits, but headwinds coming

Read Article
Wed, 21 Sep 2022

Homegrown pharmaceutical firm takes long view

Read Article
Mon, 19 Sep 2022

Douglas Pharmaceuticals gears up R&D

Read Article
Wed, 14 Sep 2022
1 16 17 18 19 20 52